Stifel Financial Corp cut its stake in BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 6.7% in the third quarter, HoldingsChannel reports. The firm owned 6,137 shares of the company’s stock after selling 440 shares during the quarter. Stifel Financial Corp’s holdings in BlackRock Health Sciences Trust were worth $257,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Wolverine Asset Management LLC raised its holdings in BlackRock Health Sciences Trust by 360.1% in the second quarter. Wolverine Asset Management LLC now owns 60,108 shares of the company’s stock valued at $2,455,000 after acquiring an additional 47,044 shares in the last quarter. Consolidated Portfolio Review Corp increased its holdings in BlackRock Health Sciences Trust by 133.8% in the second quarter. Consolidated Portfolio Review Corp now owns 39,721 shares of the company’s stock valued at $1,623,000 after buying an additional 22,729 shares during the last quarter. International Assets Investment Management LLC purchased a new position in BlackRock Health Sciences Trust in the third quarter valued at $8,610,000. Logan Stone Capital LLC acquired a new stake in BlackRock Health Sciences Trust in the second quarter valued at $600,000. Finally, City of London Investment Management Co. Ltd. purchased a new stake in BlackRock Health Sciences Trust during the 2nd quarter worth about $429,000.
BlackRock Health Sciences Trust Stock Down 0.4 %
NYSE:BME opened at $38.32 on Monday. BlackRock Health Sciences Trust has a 1 year low of $36.87 and a 1 year high of $42.86. The stock has a 50-day simple moving average of $39.50 and a 200-day simple moving average of $40.68.
BlackRock Health Sciences Trust Announces Dividend
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
See Also
- Five stocks we like better than BlackRock Health Sciences Trust
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- Why is the Ex-Dividend Date Significant to Investors?
- These 3 Quirky ETFs May Be Strong Plays in 2025
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.